Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Galera reports updated phase I/II study data on GC-4419 in locally advanced pancreatic cancer

April 29, 2021

NFX1-123 as a promising new therapeutic target in cancer

April 29, 2021

G1 Therapeutics initiates registrational study of Cosela in mTNBC

April 29, 2021

ESSA and Bayer enter clinical collaboration to evaluate EPI-7386 plus darolutamide in mCRPC

April 29, 2021

Pfizer details development of clinical PRMT5 inhibitor candidate PF-06939999

April 29, 2021

Agios Pharmaceuticals and the University of Michigan describe menin/MLL interaction inhibitors

April 29, 2021

Kainos Medicine presents new IRAK-4 inhibitors

April 29, 2021

New Bruton tyrosine kinase inhibitors identified at Newave Pharmaceutical

April 29, 2021

Haihe starts first-in-human study of HH-30134 in advanced solid tumors

April 29, 2021

KRAS G12C inhibitor BI-1823911 shows in vivo efficacy, to enter clinical study

April 28, 2021

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...